Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

257 та иш

Иш: Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)

  1. Sudden, unexpected death in avid dieters using the liquid-protein-modified-fast diet. Observations in 17 patients and the role of the prolonged QT interval.

    J M Isner, H E Sours, Alberto Paris +2

    Мақола19792 иқтибос
    ABI

  2. Effect of Obesity on Short‐ and Long‐term Mortality Postcoronary Revascularization: A Meta‐analysis

    Antigone Oreopoulos, Raj Padwal, Colleen M. Norris +3

    Шарҳ мақола20082 иқтибос
    ABI

  3. Echocardiography and Risk Prediction in Advanced Heart Failure: Incremental Value Over Clinical Markers

    Syed A. Agha, Andreas P. Kalogeropoulos, Jeffrey Shih +10

    Мақола20092 иқтибос
    ABI

  4. Association of Body Mass Index With Major Cardiovascular Events and With Mortality After Percutaneous Coronary Intervention

    Duk‐Woo Park, Young‐Hak Kim, Sung‐Cheol Yun +8

    Шарҳ мақола20132 иқтибос
    ABI

  5. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort

    Rajeev K. Pathak, Melissa E. Middeldorp, Megan Meredith +9

    Мақола20152 иқтибос
    ABI

  6. Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors

    Rachel Huxley, Faye L. Lopez, Aaron R. Folsom +6

    Мақола20112 иқтибос
    ABI

  7. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives

    Ewa A. Jankowska, S. von Haehling, Stefan D. Anker +2

    Шарҳ мақола20122 иқтибос
    ABI

  8. Sagittal Abdominal Diameter and Risk of Sudden Death in Asymptomatic Middle-Aged Men

    Jean‐Philippe Empana, Pierre Ducimetière, Marie‐Aline Charles +1

    Мақола20042 иқтибос
    ABI

  9. Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents

    Ajay Gupta, Shazia Arshad, Neil R Poulter

    Шарҳ мақола20092 иқтибос
    ABI

  10. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

    Helen B. Hubert, M Feinleib, Patricia McNamara +1

    Мақола19832 иқтибос
    ABI

  11. Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors

    Aldo P. Maggioni, Inder S. Anand, Sidney O. Gottlieb +3

    Мақола20022 иқтибос
    ABI

  12. Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study

    David N. Juurlink, Muhammad Mamdani, Douglas S. Lee +4

    Мақола20042 иқтибос
    ABI

  13. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure

    John G.F. Cleland, William T. Abraham, Cecilia Linde +6

    Шарҳ мақола20132 иқтибос
    ABI

  14. Healthy Lifestyle Through Young Adulthood and the Presence of Low Cardiovascular Disease Risk Profile in Middle Age

    Kiang Liu, Martha L. Daviglus, Catherine M. Loria +4

    Мақола20122 иқтибос
    ABI

  15. A new algorithm for transthoracic cardioversion of atrial fibrillation based on body weight

    Eric J. Rashba, Rachida Bouhouch, Sunita Koshy +4

    Мақола20012 иқтибос
    ABI

  16. Renal dysfunction and heart failure: things are seldom what they seem

    Gerasimos Filippatos, Dimitrios Farmakis, John Parissis

    Бошқа20132 иқтибос
    ABI

  17. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years

    Teresa S.M. Tsang, Marion E. Barnes, Yoko Miyasaka +5

    Мақола20082 иқтибос
    ABI

  18. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study

    Amir A. Mahabadi, Joseph M. Massaro, Guido Aranha Rosito +6

    Мақола20082 иқтибос
    ABI

  19. The Levels of Soluble CD40 Ligand and C-Reactive Protein in Normal Weight, Overweight and Obese People

    İlkay Tuğba Ünek, Fırat Bayraktar, Dilek Solmaz +4

    Мақола20102 иқтибос
    ABI

  20. Association of Overweight With Increased Risk of Coronary Heart Disease Partly Independent of Blood Pressure and Cholesterol Levels<subtitle>A Meta-analysis of 21 Cohort Studies Including More Than 300 000 Persons</subtitle>

    Rik Bogers

    Шарҳ мақола20072 иқтибос
    ABI

  21. Obesity and Antiplatelets-Does One Size Fit All?

    Craig J. Beavers, Paula M. Heron, Susan S. Smyth +2

    Шарҳ мақола20152 иқтибос
    ABI

  22. Comparison of Bruce Treadmill Exercise Test Protocols: Is Ramped Bruce Equal or Superior to Standard Bruce in Producing Clinically Valid Studies for Patients Presenting for Evaluation of Cardiac Ischemia or Arrhythmia with Body Mass Index Equal to or Greater Than 30?

    Angela Macci Bires, J. David Lawson, Thomas Wasser +1

    Мақола20132 иқтибос
    ABI

  23. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

    Salim Yusuf, Marc A. Pfeffer, Karl Swedberg +6

    Мақола20032 иқтибос
    ABI

  24. Intramyocardial Adiposity After Myocardial Infarction

    Jim Pouliopoulos, W. Chik, A. Kanthan +9

    Мақола20132 иқтибос
    ABI

  25. Body Mass Index, Waist/Hip Ratio, and Coronary Heart Disease Incidence in African Americans and Whites

    A.R Folsom, June Stevens, Pamela J. Schreiner +2

    Мақола19982 иқтибос
    ABI